Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS0159 in Chinese Healthy Subjects
Clinical trial NCT05624294 · COMPLETED
Trial details
- NCT number
- NCT05624294
- Sponsor
- Cascade Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-19
- Primary completion
- 2023-03-28
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.